Landmark 10-Year Study Strengthens Long-Term Evidence Supporting Focal TherapyIndependent research from a UK group demonstrates durable long-term tissue ablation, while Sonablate’s extensive clinical use reflects its role in advancing HIFU technology worldwide
Sonablate Launches SONA FUSION Global Registry to Advance Precision Sound Medicine and Define Future Standards in Focal TherapyFirst multinational initiative dedicated to long-term HIFU outcomes in prostate cancer and BPH aims to help close the evidence gap in incision-free prostate care
Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer TreatmentAppointment signals next phase of expansion for HIFU-based prostate care as demand grows for non-invasive, function-preserving treatment options
Sonablate Expands Leadership to Accelerate Growth in Incision-Free Prostate Care SolutionsAppointments support rising demand for HIFU and advance the “precision sound medicine” platform across new clinical applications
